| Reference |
|---|
Golubovskaya V, Sienkiewicz J, Sun J, Huang Y, Hu L, Zhou H, et al. mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth. Cancers (Basel). 2023;15: pubmed publisher |
Lubin J, Markosian C, Balamurugan D, Ma M, Chen C, Liu D, et al. Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion. JCI Insight. 2023;8: pubmed publisher |
Gall C, Fennemann F, van der Schoot J, Scheeren F, Verdoes M. CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells. Bio Protoc. 2023;13:e4613 pubmed publisher |
Zhang M, Wang L, Liu J, Pang Y. Envelope virus-mimetic nanovaccines by hybridizing bioengineered cell membranes with bacterial vesicles. iScience. 2022;25:104490 pubmed publisher |
Liu L, Iketani S, Guo Y, Reddem E, Casner R, Nair M, et al. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Sci Transl Med. 2022;14:eabn6859 pubmed publisher |
Pivniouk V, Pivniouk O, Devries A, Uhrlaub J, Michael A, Pivniouk D, et al. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression. J Allergy Clin Immunol. 2022;149:923-933.e6 pubmed publisher |
Huang H, Lai Y, Liao C, Yang W, Huang K, Lee I, et al. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine. 2021;74:103712 pubmed publisher |
Zhu Q, Shan S, Yu J, Peng S, Sun C, Zuo Y, et al. A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nat Commun. 2021;12:6624 pubmed publisher |
Sokal A, Barba Spaeth G, Fern xe1 ndez I, Broketa M, Azzaoui I, de La Selle A, et al. mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants. Immunity. 2021;54:2893-2907.e5 pubmed publisher |
Tong P, Gautam A, Windsor I, Travers M, Chen Y, Garcia N, et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. Cell. 2021;184:4969-4980.e15 pubmed publisher |
Long Y, Song S, Luo F, Han X, Hu C, Wang Y, et al. A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding. Biochem Biophys Res Commun. 2021;571:152-158 pubmed publisher |
Wang R, Zhang Q, Ge J, Ren W, Zhang R, Lan J, et al. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021;54:1611-1621.e5 pubmed publisher |
Huang J, Lee H, Zhao X, Han J, Su Y, Sun Q, et al. Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93. Immunity. 2021;54:673-686.e4 pubmed publisher |
Scheu A, Lim S, Metzner F, Mohammed S, Howarth M. NeissLock provides an inducible protein anhydride for covalent targeting of endogenous proteins. Nat Commun. 2021;12:717 pubmed publisher |
Le Gall C, van der Schoot J, Ramos Tomillero I, Khalily M, van Dalen F, Wijfjes Z, et al. Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering. Bioconjug Chem. 2021;32:301-310 pubmed publisher |
Tasker C, Patel J, Jawa V, Maamary J. Competition-Based Cell Assay Employing Soluble T Cell Receptors to Assess MHC Class II Antigen Processing and Presentation. AAPS J. 2021;23:26 pubmed publisher |
Alberts A, Klingberg A, Hoffmeister L, Wessig A, Brand K, Pich A, et al. Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures. Front Immunol. 2020;11:596103 pubmed publisher |
Wei C, Wan L, Yan Q, Wang X, Zhang J, Yang X, et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020;2:1391-1400 pubmed publisher |
Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020;586:572-577 pubmed publisher |
Jandke A, Melandri D, Monin L, Ushakov D, Laing A, Vantourout P, et al. Butyrophilin-like proteins display combinatorial diversity in selecting and maintaining signature intraepithelial γδ T cell compartments. Nat Commun. 2020;11:3769 pubmed publisher |
Li Z, Deng M, Huang F, Jin C, Sun S, Chen H, et al. LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cell Mol Immunol. 2020;17:272-282 pubmed publisher |
van der Schoot J, Fennemann F, Valente M, Dölen Y, Hagemans I, Becker A, et al. Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering. Sci Adv. 2019;5:eaaw1822 pubmed publisher |
